Why the study?
Does female gender increase in-hospital mortality in patients with STEMI undergoing reperfusion therapy?
Cohort (n=816)
No
Does female gender increase in-hospital mortality in patients with STEMI undergoing reperfusion therapy?
Answers are grounded in this paper and cite their sources.
Female gender is associated with a significantly higher risk of in-hospital mortality compared to men in patients with STEMI undergoing reperfusion therapy.
Aim. To evaluate the effect of gender on mortality from acute myocardial infarction with elevated ST segment (STEMI). Materials and methods. In this single-centre retrospective study, we analyzed outcomes of the in-hospital stage of the treatment of 553 men (67,7%) and 263 women (32.3%). 160 women (60,8%) underwent primary percutaneous coronary intervention (pPCI) and 103 pharmacoinvasive strategy (FAST-PCI), (39,2%). The same treatment was given to 295 (53,3%) and 258 (46,7%) men respectively. Patients with “primary medical contact (PMC) - balloon” of less than 60 minutes and “PMC - balloon” symptom” of more than 6 hours were excluded from the study. For the majority of the patients this time interval was on the order of 120 minutes. Results. Mortality in women was significantly higher than in men regardless of the reperfusion strategy: total 15.3 percent (18.1 percent in case of PCCW and 10.9% in case of FIS) in women and 3.1% (5.1% in case of PCCW and 0.8% in case of FIS) in men (p < 0.001). The probability of a lethal outcome in women was 4 times higher (OR 4,4 DI 95% 2,7-7,1).
No takes yet. Share an insight, caveat, or question.
Nemik et al. (2017) conducted a cohort in Acute myocardial infarction with elevated ST segment (STEMI) (n=816). Female sex vs. Male sex was evaluated on In-hospital mortality (OR 4.4, 95% CI 2.7-7.1, p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: